DATATRAK International, Inc. announced that Mr. Craig Wigginton joined the company as Chief Technology Officer, responsible for setting and executing the company's technical vision with the software development and IT operations teams. Mr. Wigginton brings more than 20 years of product development, software engineering and architecture experience, with recent success in healthcare supply chain management, medical and behavioral health management and telecommunications. At the Annual Meeting of Shareholders held on May 14, 2013, the shareholders approved the election of new board member, Mr. Nicholas A. Loiacono, currently the Vice President and Treasurer of McKesson Corporation. Mr. Loiacono began his career in healthcare over 30 years ago with American Hospital Supply Corporation. He brings a wealth of experience in healthcare manufacturing and distribution, medical devices, clinical laboratory, home healthcare and healthcare information technologies. The company reported unaudited consolidated earning results for first quarter ended March 31, 2013. For the period the company reported revenue was $2,582,477 compared to $2,119,198 in the same period last year due to strong new contract sales which fueled backlog increases throughout 2012 and in the first quarter of 2013 as well. Loss from operations was $389,117 compared to $515,277 in the same period last year. Interest income was $93 compared to $132 in the same period last year. Net income was $357,826 or 0.02 per basic share compared to loss of $516,800 or $0.04 per share in the same period last year.

DATATRAK International, Inc. announced an Israeli biopharmaceutical company chose to standardize on the DATATRAK ONE(TM) clinical research platform for its oncology program. Understanding the benefit of the unified platform, they will utilize multiple products and modules within the software suite -- uEDC, including medical coding and uIRT, including both Randomization and Clinical Supplies Management -- to reduce the cost of their clinical trials. The DATATRAK ONE(TM) Clinical Research Platform is an easy to use, cloud-based clinical enterprise solution that empowers Sponsors and CROs to efficiently design, deliver and manage clinical trials. From strategy and planning to resource management and study execution needs, clients manage their entire product portfolio in a single system with one username and password. DATATRAK's unified clinical enterprise solution consists of seven products: uCTMS, uDesign, uEDC, uIRT, uSafety, uTrain and uCDR.

DATATRAK International, Inc. announced unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2012. For the quarter, the company reported revenue of $2,776,589 compared to $1,854,481 a year ago. Loss from operations was $99,840 compared to $426,048 a year ago. Net loss was $101,171 or $0.01 per basic and diluted share compared to $434,188 or $0.03 per basic and diluted share a year ago. For the year, the company reported revenue of $9,716,225 compared to $7,926,342 a year ago. Loss from operations was $1,529,209 compared to $1,243,613 a year ago. Net loss was $1,539,348 or $0.10 per basic and diluted share compared to $1,006,887 or $0.07 per basic and diluted share a year ago.